Today's lecture focuses on multi exponential pharmacokinetics (PK) and the transition from mono exponential PK.
Lecture Objectives:
Understand multi exponential PK and its role in pharmacokinetics.
Differentiate between mono exponential and multi exponential models.
Understand the mathematical basis of multi exponential PK.
Apply multi exponential PK models to calculate pharmacokinetic parameters.
Use case studies to enhance understanding.
The simplest model, assumes:
Instantaneous distribution of drug following administration (IV bolus).
Elimination occurs solely from the central compartment (blood).
Divides the body into two compartments:
Central Compartment: Blood, plasma, and highly perfused tissues (liver, kidney).
Peripheral Compartment: Low perfused tissues (bone, fat).
Drug enters the central compartment and achieves dynamic equilibrium with the peripheral compartment governed by rate constants.
Elimination occurs from the central compartment, with distribution and redistribution between compartments.
Models can be expanded to three compartments and beyond to account for more complex drug behavior.
Useful for drugs that localize in specific tissues, such as:
Statins: Inhibit reductase action in the liver.
Digoxin: Distributes into cardiac tissue for effect.
Thyroxine and Diazepam: Exhibit high affinity to tissue proteins.
Initial distribution phase followed by an elimination phase.
Plotting concentration vs. time shows:
Rapid decline during distribution phase.
Slower decline during terminal elimination phase.
The distribution phase (alpha) involves both elimination and redistribution, while the terminal phase (beta) reflects true elimination.
K12: Distribution rate from central to peripheral compartment.
K21: Redistribution rate from peripheral to central compartment.
Body divided into compartments representing physiological spaces.
First order kinetics where elimination is proportional to drug concentration.
Homogeneity assumed within compartments, with drug evenly distributed.
Monitoring of drug concentration occurs in blood (central compartment).
Characterized by instantaneous distribution and elimination.
Exhibits simple exponential decay without biphasic patterns.
Example: Gentamicin - exhibits rapid elimination due to hydrophilic nature and limited tissue distribution.
Allows for delayed distribution and compartmental behaviors.
Characterized by drug concentrations reflecting both distribution and elimination rates, leading to bi exponential decay.
KEL (K10): Elimination rate constant.
K12: First order distribution from the central to the peripheral compartment.
K21: First order redistribution from the peripheral to the central compartment.
Involves distinct calculations for central and peripheral compartments, varying between:
Volume of distribution immediately after administration.
Volume of distribution during terminal phase.
Volume of distribution at steady state.
Defined as the time taken for drug concentration to decrease by 50%:
Alpha phase: 0.693/alpha
Beta phase: 0.693/beta (true biological half life).
Importance of half life varies between compartment models due to redistribution effects.
Example demonstrates two compartment model:
Time vs. concentration plots show initial rapid decline followed by slower terminal decline.
Effect observed relates strongly to plasma concentration dynamics, particularly the anti-clockwise hysteresis seen with digoxin.
Concentration at time (t) = A * e^(alpha * t) + B * e^(beta * t)
A & B: Empirical coefficients calculated from data.
Alpha and Beta: Define slopes of distribution and elimination.
Allows separation of elimination from distribution phase to accurately determine rate constants.
Involves plotting residuals and extracting slope information to define parameters.
Multi exponential models provide a more accurate representation of drug distribution and elimination than mono exponential models.
Understanding the compartmental analysis is crucial for calculating pharmacokinetic parameters and applying them in clinical scenarios.